Overview
Paul Dickman practices in Stockholm, Sweden. Mr. Dickman is rated as a Distinguished expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myeloproliferative Neoplasms (MPN), Hodgkin Lymphoma, Chronic Myelogenous Leukemia (CML), Splenectomy, and Cystectomy.
His clinical research consists of co-authoring 88 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Stockholm, AB, Sweden
Solna, AB, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myeloproliferative Neoplasms (MPN)Mr. Dickman isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Advanced
- Hodgkin LymphomaMr. Dickman isAdvanced. Learn about Hodgkin Lymphoma.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Dickman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMr. Dickman isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerMr. Dickman isExperienced. Learn about Breast Cancer.
- Chronic Myelogenous Leukemia (CML)Mr. Dickman isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Colorectal CancerMr. Dickman isExperienced. Learn about Colorectal Cancer.
- CystectomyMr. Dickman isExperienced. Learn about Cystectomy.